Advertisement
UK markets close in 5 hours 34 minutes
  • FTSE 100

    8,088.81
    +48.43 (+0.60%)
     
  • FTSE 250

    19,726.28
    +6.91 (+0.04%)
     
  • AIM

    755.18
    +0.49 (+0.06%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2513
    +0.0051 (+0.41%)
     
  • Bitcoin GBP

    51,085.57
    -1,945.77 (-3.67%)
     
  • CMC Crypto 200

    1,362.35
    -20.23 (-1.46%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.68
    -0.13 (-0.16%)
     
  • GOLD FUTURES

    2,338.30
    -0.10 (-0.00%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,982.72
    -105.98 (-0.59%)
     
  • CAC 40

    8,043.51
    -48.35 (-0.60%)
     

Why iTeos Therapeutics Stock Soared Today

Why iTeos Therapeutics Stock Soared Today

Shares of iTeos Therapeutics (NASDAQ: ITOS) surged 37% on Monday after it reached an agreement with GlaxoSmithKline (NYSE: GSK) to co-develop an experimental cancer treatment known as EOS-448. EOS-448 is a monoclonal antibody treatment for patients with cancer. GlaxoSmithKline also intends to begin new combination studies of EOS-448 with some of its other immuno-oncology therapies next year.